von Tobias Borgers | Dez 4, 2021 | Boehringer
The information below has been supplied by dairy marketers and other industry organizations. It has not been edited, verified or endorsed by Hoard’s Dairyman.Vaxxinova® announced today that it has purchased Newport Laboratories, a company that manufactures custom-made...
von Tobias Borgers | Dez 4, 2021 | Bayer
Leverkusen, 30. November 2021 – Gesundheit in Deutschland gemeinsam gestalten – mit diesem Leitspruch macht Bayer deutlich, dass Partnerschaften eine zentrale Rolle für die zukünftige Innovationsstrategie des Unternehmens spielen. „Durch die biomedizinische und...
von Tobias Borgers | Nov 30, 2021 | Bayer
Der Konzern will sich noch stärker auf das Kerngeschäft mit Kunden aus der Landwirtschaft konzentrieren. Frankfurt Bayer kommt bei der geplanten Trennung von seinem Geschäftsbereich Environmental Science voran. Der Leverkusener Konzern hat Finanzkreisen zufolge Bieter...
von Tobias Borgers | Nov 30, 2021 | Boehringer
PLEASANTON, Calif.–(BUSINESS WIRE)–Boehringer Ingelheim, a top 20 global pharmaceutical company, is standardizing on Veeva CRM Engage Meeting to drive more valued interactions between its global field organization and healthcare providers (HCPs). The...
von Tobias Borgers | Nov 28, 2021 | Boehringer
For 2021, Boehringer Ingelheim expects to achieve a slight year-on-year increase in net sales on a comparable basis Germany-based pharmaceutical firm Boehringer Ingelheim stepped up its investments in R&D significantly in 2020 in pursuit of innovative medicines...
von Tobias Borgers | Nov 23, 2021 | Bayer
Amid a flurry of moves by major pharmaceutical companies to separate themselves from their consumer health businesses, investors in companies that are resisting change are asking the question: Why not us? On Thursday, Bayer CEO Werner Baumann addressed the elephant in...
